After more than a decade of the widely publicized recall of the fen-phen weight-loss cocktail was withdrawn from the market due to serious side effects that affected the heart and lungs, the maker of Suprenza, is being reprimanded by the FDA for leaving out pertinent information regarding the drug on their website. Amid their get "LEAN" campaign blasted all over their website, the makers of this new magic pill erroneously forgot to list all of the warnings and precautions that come along with taking the drug.
According to the letter sent by the FDA to Citius and Akrimax Pharmaceuticals, the patentee and marketer for the drug, the website for Suprenza manages to omit everything from the website regarding all of the contradictions and adverse reactions that come along with taking this drug. The website only warns of the risks of taking their pill with other weight-loss drugs and has a link to prescribing information.
Ed Silverman of the Wall Street Journal, states that the FDA officials maintain that the presentation for Suprenza is misleading because it suggests patients will become lean after taking Suprenza. The website for Suprenza is misleading and leads consumers to believe that the drug is safer than has been demonstrated. The FDA urges drug manufacturers and marketers to ensure that their consumers are fully informed of all risks associated with taking any new drug, regardless of the reason for such omissions.
If you or a loved one have been injured as a result of a taking a diet drug, contact an attorney at Abraham, Watkins, Nichols, Sorrels, Agosto & Friend by calling 713-222-7211 or 1-800-870-9584.